Back to
Hudson Bay Capital Management LP
STLN
3 quarters
Position history for
Hudson Bay Capital Management LP's holdings in Starling Oncology, Inc.
No. Hudson Bay Capital Management exited its STLN (Starling Oncology) position in Q3 2025. Its Q2 2025 13F listed 15,200 shares worth $31,160. Hudson Bay Capital Management first reported STLN in Q1 2025 and held it in 2 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$17,328
Total Shares Change
-15,200
Quarter-by-Quarter History